MedMira Inc. 47M.F Stock
MedMira Inc. Price Chart
MedMira Inc. 47M.F Financial and Trading Overview
MedMira Inc. stock price | 0.06 EUR |
Previous Close | 0.06 EUR |
Open | 0.06 EUR |
Bid | 0.06 EUR x 28571500 |
Ask | 0.07 EUR x 11428600 |
Day's Range | 0.06 - 0.06 EUR |
52 Week Range | 0.03 - 0.11 EUR |
Volume | 9K EUR |
Avg. Volume | 1.59K EUR |
Market Cap | 42.93M EUR |
Beta (5Y Monthly) | 10.33189 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 EUR |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
47M.F Valuation Measures
Enterprise Value | 52.5M EUR |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 57.72372 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 70.589 |
Enterprise Value/EBITDA | -34.027 |
Trading Information
MedMira Inc. Stock Price History
Beta (5Y Monthly) | 10.33189 |
52-Week Change | -29.14% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.11 EUR |
52 Week Low | 0.03 EUR |
50-Day Moving Average | 0.06 EUR |
200-Day Moving Average | 0.06 EUR |
47M.F Share Statistics
Avg. Volume (3 month) | 1.59K EUR |
Avg. Daily Volume (10-Days) | 900 EUR |
Shares Outstanding | 697.45M |
Float | 200.34M |
Short Ratio | N/A |
% Held by Insiders | 70.39% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | July 31, 2022 |
Most Recent Quarter (mrq) | January 31, 2023 |
Next Fiscal Year End | July 31, 2023 |
Profitability
Profit Margin | -268.51% |
Operating Margin (ttm) | -211.38% |
Gross Margin | -50.63% |
EBITDA Margin | -207.45% |
Management Effectiveness
Return on Assets (ttm) | -23.74% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 743.79K EUR |
Revenue Per Share (ttm) | 0.001 EUR |
Quarterly Revenue Growth (yoy) | -42.69% |
Gross Profit (ttm) | -512509 EUR |
EBITDA | -1543002 EUR |
Net Income Avi to Common (ttm) | -1997183 EUR |
Diluted EPS (ttm) | 0 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 124.83K EUR |
Total Cash Per Share (mrq) | 0 EUR |
Total Debt (mrq) | 9.38M EUR |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.113 |
Book Value Per Share (mrq) | -0.019 |
Cash Flow Statement
Operating Cash Flow (ttm) | -741014 EUR |
Levered Free Cash Flow (ttm) | -619977 EUR |
Profile of MedMira Inc.
Country | Germany |
State | NS |
City | Halifax |
Address | 155 Chain Lake Drive |
ZIP | B3S 1B3 |
Phone | N/A |
Website | https://www.medmira.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | N/A |
MedMira Inc., a biotechnology company, researches, develops, manufactures, and commercializes rapid diagnostics and technology platforms in North America, Europe, the Asia Pacific, and internationally. The company offers Reveal HIV that detects antibodies to HIV-1 and HIV-2 in whole blood, serum, or plasma; Reveal TP, a rapid syphilis antibody test that detects treponema pallidum antibodies in serum, plasma, or whole blood; Multiplo, a line of multiplex tests, including combination testing solutions for HIV-1/2, Hepatitis B and C, and syphilis; and Miriad triple product to perform preliminary screening of HIV and hepatitis. It also provides Miriad RVF toolkit that facilitates the development and commercialization of rapid diagnostics; and Reveal HP, a rapid H. Pylori antibody test, which detects helicobacter pylori (HP) antibodies in serum, plasma, or whole blood produced in response to HP infection. In addition, the company offers VYRA CoV2 that detects antigens specific for the nucleocapsid region of SARS-CoV-2; VYRA CoV2Flu, a combination viral nucleocapsid antigen tests that detects infection caused by SARS-CoV-2, and Influenza A and Influenza B; and REVEALCOVID-19, an antibody test. It sells its products through a network of medical distributors and strategic business development partners to customers in various sectors of the healthcare industry, including laboratories, hospitals, point-of-care clinics, governments, aid organizations, and public health agencies. The company was founded in 1993 and is headquartered in Halifax, Canada. MedMira Inc. is a subsidiary of MedMira Holding AG.
Q&A For MedMira Inc. Stock
What is a current 47M.F stock price?
MedMira Inc. 47M.F stock price today per share is 0.06 EUR.
How to purchase MedMira Inc. stock?
You can buy 47M.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for MedMira Inc.?
The stock symbol or ticker of MedMira Inc. is 47M.F.
Which industry does the MedMira Inc. company belong to?
The MedMira Inc. industry is Biotechnology.
How many shares does MedMira Inc. have in circulation?
The max supply of MedMira Inc. shares is 824M.
What is MedMira Inc. Price to Earnings Ratio (PE Ratio)?
MedMira Inc. PE Ratio is now.
What was MedMira Inc. earnings per share over the trailing 12 months (TTM)?
MedMira Inc. EPS is 0 EUR over the trailing 12 months.
Which sector does the MedMira Inc. company belong to?
The MedMira Inc. sector is Healthcare.